|
Market Cap (17-May) $95,239,352 (971st) |
Close (9-Dec) $1.04 |
Volume (9-Dec) 0 |
Shortsold (3-Dec) 50,000 (0.05%) (513th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.144 |
BD1 released this announcement to the ASX on 12 November 2021, 9:41. The announcement is not marked as price sensitive, and is 1 page(s) in length and 117.15kb in size.
You can view all announcements from BD1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, BD1 was 0.054% short sold according to ASIC data. It was ranked the 509th most shorted stock on the ASX. It remains ranked 513th as of the latest reported data (03 December 2021).
| Other Recent Announcements from BD1 | |
|---|---|
| BARD1 Changes its Name to INOVIQ | 8 December 2021, 8:58 |
| Cleansing Notice - Issued of Four Shares - Resolution 5 AGM | 7 December 2021, 12:12 |
| Application for quotation of securities - BD1 | 7 December 2021, 12:06 |
| US Patent Issued - BARD1 Patent Family Lung Cancer Diagnosis | 12 November 2021, 9:41 |
| EXO-NET ANZSEV Presentation | 10 November 2021, 13:14 |
| BARD1 Presenting at Bell Potter Healthcare Conference | 10 November 2021, 11:56 |
| EXO-NET Presented at Virtual ANZSEV Symposium | 10 November 2021, 9:42 |
You must be logged in to post a reply.
BARD1 Life Sciences 